8622 — Huakang Biomedical Holdings Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Huakang Biomedical Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	41.9	36.2	33.3	32.9	36.5
Net Total Accounts Receivable
Net Total Receivables	10.3	11.7	15.5	15.6	14.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	59	53.7	53.4	53.4	54.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10.8	10.4	8.27	9.74	9.04
Net Intangible Assets
Long Term Investments
Total Assets	72.7	67.1	66.4	65.3	65.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.27	8.64	9.78	13.1	11.2
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	10.8	9.36	9.88	14.3	11.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	61.9	57.7	56.5	51	54
Total Liabilities & Shareholders' Equity	72.7	67.1	66.4	65.3	65.2
Total Common Shares Outstanding